NA | Myferon 150 Forte [MARTIN EKWEALOR PHARMACEUTICALS, INC.] | BioPortfolio

13:39 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Myferon 150 Forte capsules are highly water soluble low molecular weight polysaccharide iron complex and vitaminns.

Each capsule contains:

Elemental Iron .......... 150 mg(as Polysaccharide Iron Complex)

Folic Acid .................. 1 mg

Vitamin B 12 ............... 25 mcg.(Cyanocobalamin)

Other ingredients: Microcrystalline Cellulose, Gelatin, Dicalcium, Phosphate, Stearic Acid, Pharmaceutical Glaze, Magnesium Stearate, Iron Oxides, Titanium Dioxide, FD and C Red #40 Lake and FD and C Blue #1 Lake.

Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid by dihydrofolate reductase. Vitamin B 12 is required for the maintenance of normal erythhropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of Vitamin B 12 from the gastric tract.

Myferon 150 Forte is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.

Myferon 150 Forte is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 is deficient.

General: Do not exceed recommended dose.

The type of anemia and the underlying cause or causes should be determined before starting therapy with Myferon 150 Forte. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected. If possible.

Folic Acid: Folic Acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.

Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

Geriatric Use: Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools, and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematamesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Chronic toxicity studies in rats and dogs administered polysaccharide iron complex showed that a daily dosage of 250 mg iron/kg. for three months had no adverse effects. The oral LD50 of polysaccharide iron complex was estimated to be greater than 5000 mg/kg in rats.

Myferon 150 Forte is supplied in Unit Dose blister packs, 10 capsules per card. Capsules are opaque maroon. Store at 25° C (77° F); excursions permitted to 15° -30° C (59° -86° F). (See USP controlled Room Temperature). Avoid excessive heat 40° C (104° F). Avoid freezing.


All prescription substitutions using this product shall be pursuant to state statues as applicable. This is not an Orange Book Product.



Myferon™ 150 Forte Capsules

150 mg of elemental iron1 mg of folic acid25 mcg vitamin B12

100            Rx Only

10 x 10 Unit Dose Capsules

Mfg. by M.E. Pharmaceuticals, Inc.Richmond, IN 47374 USA



Active Ingredients


Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Epiduo forte [galderma laboratories, l.p.]

These highlights do not include all the information needed to use EPIDUO FORTE gel safely and effectively. See full prescribing information for EPIDUO FORTE gel. EPIDUO FORTE (adapalene and benzoyl pe...

Strovite forte [everett laboratories, inc.]


Naphcon® forte(naphazoline hydrochlorideophthalmic solution usp), 0.1% [alcon]

NAPHCON® FORTE(naphazoline hydrochlorideophthalmic solution USP), 0.1%

Robinul [shionogi inc.]

Robinul and Robinul Forte

Pred forte [allergan, inc.]

PRED   FORTE (prednisolone acetate ophthalmic suspension, USP) 1% sterile

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Observational Program Neo-Penotran® Forte

Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvo...

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With EpiDuo Forte Gel

This will be an open-label study designed to assess the safety and plasma PK of topically applied IDP-126 Gel compared to Epiduo Forte Gel.

Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.

Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of th...

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of th...

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Factors Associated With Long-Term Outcomes After Injury: Results of the Functional Outcomes and Recovery After Trauma Emergencies (FORTE) Multicenter Cohort Study.

The aim of this study was to determine factors associated with patient-reported outcomes, 6 to 12 months after moderate to severe injury.

Comparative evaluation of fluoride release and recharge potential of novel and traditional fluoride-releasing restorative materials: An study.

The aim of this study was to evaluate and compare the fluoride ion release and uptake of glass ionomer cement GP IX Extra (GE), EQUIA Forte Fil (EF), Beautifil Bulk (BB), Dyract XP (DXP), Tetric N-Cer...

Efficient and accurate determination of C T and T relaxation time constants of high-mobility polymers from limited-resolution spectra with optimized pulse sequences and data fitting.

The pulse sequences for the measurement of C T and T relaxation time constants in soft organic solids were modified to include steady-state nuclear Overhauser enhancement with direct polarization (ssN...

Randomized clinical trial to evaluate the efficacy of prostaglandin F to treat purulent vaginal discharge in lactating dairy cows.

The objectives of this study were (1) to assess the effect of purulent vaginal discharge (PVD) on reproductive performance using a 4-point vaginal discharge score (VDS) and (2) to evaluate the effect ...

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record